Wireframe preview

Best viewed on desktop.

This is a wireframe for review, not the finished site. The responsive (mobile) treatment comes in the design and build phase. Open this page on a screen at least 1200 px wide to see the layout as intended.

← The GRA Portfolio

Abby Med

Therapeutics for malignant gliomas

Abby Med has invented a novel class of cancer drugs targeting malignant gliomas, one of the leading causes of death from cancer.

The company’s molecules, called triphenylmethanes (TPMS), have shown to be effective against human glioma cell lines. TPMs are non-toxic and inexpensive to synthesize. Abby Med has developed a way to encapsulate TPMs for non-invasive delivery to patients.

A therapeutic agent based on TPMs could support surgical and chemotherapeutic treatments and improve survival outcomes in the 12,000 cases of glioma diagnosed in the U.S. each year.